Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Chicago, July 07, 2025 (GLOBE NEWSWIRE) -- The global video on demand market was valued at US$ 270.14 billion in 2024 and is projected to reach US$ 883.35 billion by 2033, growing at a CAGR of...
-
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced that its TransPerfect Media division,...
-
NEW YORK CITY, June 06, 2025 (GLOBE NEWSWIRE) -- Expert Consumers has named a leading VPN service as the top-ranked virtual private network for Amazon Firestick users in 2025, following an in-depth...
-
SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- Sutter Health today broke ground on the new Sutter Advanced Neuroscience Complex at Mission Bernal – a major milestone in expanding access to...
-
Dublin, May 30, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia LED TV Market by Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The...
-
Series B funding round led by Innovation Industries, with participation from Invest-NL, EIC Fund, and existing investors Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, Brabant...
-
Montara Therapeutics received a research grant from The Michael J. Fox Foundation for the development of new therapies targeting LRRK2.
-
ASUS and ROG launch new Strix, Zephyrus, and TUF Gaming laptops powered by NVIDIA GeForce RTX 5060 GPUs — available in multiple configs starting today.
-
Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for the treatment of Alzheimer’s Disease (AD) and Diabetic...
-
Therini Bio raised a $39M Series A financing, bringing the Series A total to $75M, from top-tier investors to commence THN391 Ph 1b AD and DME studies